Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 4:21 PM
Ignite Modification Date: 2025-12-24 @ 4:21 PM
NCT ID: NCT05246566
Eligibility Criteria: Inclusion Criteria: * Adult patients (≥ 18 years old) treated for SE by SAMU/SMUR and by emergencies or intensive care in the French West Indies and French Guiana. * Covered for suspected or SE diagnosis defined by one of the following: * a prolonged generalized tonic-clonic crisis lasting more than 5 minutes and accompanied by impaired consciousness or at least 2 generalized tonic-clonic crisis without return to normal consciousness between crisis. * a focal convulsive crisis (motor or not) with disturbances of consciousness which lasts beyond 10 minutes or crisis which are repeated (≥ 2) at short intervals without recovery of interictal consciousness. * a focal convulsive crisis (motor or not) without alteration of consciousness that lasts beyond 10 to 15 minutes. * an absence-type crisis that lasts longer than 10 to 15 minutes. * a myoclonic, clonic and tonic crisis that lasts longer than 10 to 15 minutes. * a coma with an epileptic cause diagnosed on an EEG. * Patient if he is able to, or representative of the patient in case of incapacity, having given his agreement for the use of his medical data for this research. Exclusion Criteria: * Age \< 18 years old * Absence of consent from the patient, or representative to the use of the data for the research. * Patient whose main residence is not in the department where the study is taking place (vacationer for example).
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT05246566
Study Brief:
Protocol Section: NCT05246566